Literature DB >> 26003558

Mesenchymal Stem Cells in IBD: unMaSCing Their Therapeutic Mechanisms.

Franco Scaldaferri1, Stefania Vetrano.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26003558     DOI： 10.1007/s10620-015-3724-7

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  10 in total

Review 1.  Inflammatory bowel disease: the role of environmental factors.

Authors:  Silvio Danese; Miquel Sans; Claudio Fiocchi
Journal:  Autoimmun Rev       Date:  2004-07       Impact factor: 9.754

2.  A phase I clinical trial of the treatment of Crohn's fistula by adipose mesenchymal stem cell transplantation.

Authors:  Damián García-Olmo; Mariano García-Arranz; Dolores Herreros; Isabel Pascual; Concepción Peiro; José Antonio Rodríguez-Montes
Journal:  Dis Colon Rectum       Date:  2005-07       Impact factor: 4.585

Review 3.  Immunomodulatory properties of mesenchymal stromal cells.

Authors:  Alma J Nauta; Willem E Fibbe
Journal:  Blood       Date:  2007-07-30       Impact factor: 22.113

4.  Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method.

Authors:  A J Friedenstein; U F Deriglasova; N N Kulagina; A F Panasuk; S F Rudakowa; E A Luriá; I A Ruadkow
Journal:  Exp Hematol       Date:  1974       Impact factor: 3.084

5.  Combinatorial Intervention with Mesenchymal Stem Cells and Granulocyte Colony-Stimulating Factor in a Rat Model of Ulcerative Colitis.

Authors:  YinHua Tang; YingYing Chen; Xi Wang; Guang Song; YongGuo Li; LiJun Shi
Journal:  Dig Dis Sci       Date:  2015-04-18       Impact factor: 3.199

Review 6.  Functions of granulocyte-macrophage colony-stimulating factor.

Authors:  Andrew J Fleetwood; Andrew D Cook; John A Hamilton
Journal:  Crit Rev Immunol       Date:  2005       Impact factor: 2.214

7.  Impaired neutrophil chemotaxis in Crohn's disease relates to reduced production of chemokines and can be augmented by granulocyte-colony stimulating factor.

Authors:  M W N Harbord; D J B Marks; A Forbes; S L Bloom; R M Day; A W Segal
Journal:  Aliment Pharmacol Ther       Date:  2006-08-15       Impact factor: 8.171

8.  Mesenchymal Stem Cells Reduce Colitis in Mice via Release of TSG6, Independently of Their Localization to the Intestine.

Authors:  Emanuela Sala; Marco Genua; Luciana Petti; Achille Anselmo; Vincenzo Arena; Javier Cibella; Lucia Zanotti; Silvia D'Alessio; Franco Scaldaferri; Giovanni Luca; Iva Arato; Riccardo Calafiore; Alessandro Sgambato; Sergio Rutella; Massimo Locati; Silvio Danese; Stefania Vetrano
Journal:  Gastroenterology       Date:  2015-03-17       Impact factor: 22.682

9.  Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial.

Authors:  Damian Garcia-Olmo; Dolores Herreros; Isabel Pascual; José Antonio Pascual; Emilio Del-Valle; Jaime Zorrilla; Paloma De-La-Quintana; Mariano Garcia-Arranz; Maria Pascual
Journal:  Dis Colon Rectum       Date:  2009-01       Impact factor: 4.585

Review 10.  Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing.

Authors:  Giselle Chamberlain; James Fox; Brian Ashton; Jim Middleton
Journal:  Stem Cells       Date:  2007-07-26       Impact factor: 6.277
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.